Get started
Author

Ryohei Furumai

FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases.
2002 · Ryohei Furumai, Akihisa Matsuyama, et al. · PubMed · 732
Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin
2000 · Ryohei Furumai, Yasuhiko Komatsu, et al. · Proceedings of the National Academy of Sciences · 411
PDF
Histone deacetylase as a new target for cancer chemotherapy
2001 · Minoru Yoshida, Ryohei Furumai, et al. · Cancer Chemotherapy and Pharmacology · 215
Perturbation of Ribosome Biogenesis Drives Cells into Senescence through 5S RNP-Mediated p53 Activation
2015 · Kazuho Nishimura, Takuya Kumazawa, et al. · Cell Reports · 165
Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity.
2001 · Y Komatsu, K Y Tomizaki, et al. · PubMed · 146
ATR functions as a gene dosage‐dependent tumor suppressor on a mismatch repair‐deficient background
2004 · Yanan Fang, Cheng‐Chung Tsao, et al. · The EMBO Journal · 112
PDF
Stable RNA Interference–Mediated Suppression of Cyclophilin A Diminishes Non–Small-Cell Lung Tumor Growth In vivo
2005 · Brandon A. Howard, Ryohei Furumai, et al. · Cancer Research · 95
PDF
Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin
2000 · R. Furumai · Proceedings of the National Academy of Sciences · 93
Protein Phosphatase 5 Is Required for ATR-Mediated Checkpoint Activation
2005 · Ji Zhang, Shideng Bao, et al. · Molecular and Cellular Biology · 85
PDF
Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF
2010 · Ryohei Furumai, Kazuyo Uchida, et al. · Cancer Science · 56
Neuronal Differentiation of Neuro 2a Cells by Inhibitors of Cell Cycle Progression, Trichostatin A and Butyrolactone I
1999 · Junji Inokoshi, Masako Katagiri, et al. · Biochemical and Biophysical Research Communications · 50
The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver
2010 · Hiroshi Oiso, Noboru Furukawa, et al. · Biochemical and Biophysical Research Communications · 45
Reduced ATR or Chk1 Expression Leads to Chromosome Instability and Chemosensitization of Mismatch Repair–deficient Colorectal Cancer Cells
2009 · Melanie J. Jardim, Qinhong Wang, et al. · Molecular Biology of the Cell · 43
The E3 Ubiquitin Ligase Activity of Trip12 Is Essential for Mouse Embryogenesis
2011 · Masashi Kajiro, Mai Tsuchiya, et al. · PLoS ONE · 42
PDF
Histone deacetylase inhibitors block nuclear factor‐κB‐dependent transcription by interfering with RNA polymerase II recruitment
2011 · Ryohei Furumai, Akihiro Ito, et al. · Cancer Science · 32
PDF
UBE3A regulates the transcription of IRF, an antiviral immunity
2019 · Ryohei Furumai, Kota Tamada, et al. · Human Molecular Genetics · 26
CHIP buffers heterogeneous Bcl-2 expression levels to prevent augmentation of anticancer drug-resistant cell population
2014 · M Tsuchiya, Y Nakajima, et al. · Oncogene · 11
Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF
2010 · Ryohei Furumai, Misao Yoneyama, et al. · The International Journal of Psychoanalysis · 3
Works count: 19
Citation count: 2,362
H-index: 16
I10-index: 17
Year
Topic
Type